Jaye L. Thompson
Technik-/Wissenschafts-/F&E-Leiter bei GREENWICH LIFESCIENCES, INC.
Vermögen: 4 Mio $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Eric Rothe | M | 49 | 18 Jahre | |
| Snehal Patel | M | 60 | 14 Jahre | |
| David McWilliams | M | 80 | 15 Jahre | |
| F. Daugherty | M | 73 | 5 Jahre | |
| Kenneth Hallock | M | 75 | 5 Jahre | |
| Christine T. Fischette | M | - | 3 Jahre | |
| Fernando Martinez | M | - |
inVentiv Clinical Solutions LLC
| 16 Jahre |
| Walter Ulrich | M | - |
Gulf Coast Regional Center of Innovation & Commercialization
| - |
| Joachim F. Wernicke | M | 76 | 11 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Joseph S. Podolski | M | 76 | 28 Jahre | |
| Larry Dillaha | M | 60 | 1 Jahre | |
| Jean L. Fourcroy | M | 93 | 9 Jahre | |
| David Hung | M | 67 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 Jahre |
| Patrick P. Fourteau | M | 77 | 2 Jahre | |
| Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 Jahre |
| Michael Wyllie | M | 73 | 7 Jahre | |
| Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 Jahre |
| Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Sona Saira Ramasastry | F | 48 | 5 Jahre | |
| Mark Lappe | M | 57 | 1 Jahre | |
| Ronald D. Wiehle | M | 75 | 19 Jahre | |
| Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 Jahre |
| Donald Tredway | M | - | - | |
| Michael Suesserman | M | 59 | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 18 | 75,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jaye L. Thompson
- Persönliches Netzwerk
